World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
63505
World Ranking
4460
National Ranking
2431

Peter A. Calabresi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter A. Calabresi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 643 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter A. Calabresi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter A. Calabresi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter A. Calabresi is affiliated with Johns Hopkins University School of Medicine in the United States. Their research primarily spans the field of Medicine, with significant contributions to subfields such as Pathology and Forensic Medicine, Neurology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Ophthalmology.

The scientist has explored a broad range of topics, including:

  • Multiple Sclerosis Research Studies
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neurogenesis and Neuroplasticity Mechanisms
  • Systemic Lupus Erythematosus Research
  • Peripheral Neuropathies and Disorders
  • Retinal and Optic Conditions
  • Ocular Diseases and Behçet's Syndrome

Peter A. Calabresi's recent papers include:

  • "A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis" (2021, published in Nature)
  • "Diagnosis and classification of optic neuritis" (2022, published in The Lancet Neurology)
  • "APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies" (2021, published in Neurology)
  • "Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation" (2020, published in Journal of Clinical Investigation)
  • "Locus for severity implicates CNS resilience in progression of multiple sclerosis" (2023, published in Nature)

The scientist frequently collaborates with several coauthors, notably Shiv Saidha, Elias S. Sotirchos, Kathryn C. Fitzgerald, Matthew D. Smith, and Ellen M. Mowry, each with dozens of joint publications.

Peter A. Calabresi's scholarly works have appeared predominantly in high-output publication venues such as Neurology, bioRxiv (Cold Spring Harbor Laboratory), Multiple Sclerosis Journal, Annals of Neurology, and Brain.

Best Publications

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

    Ludwig Kappos;Ernst Wilhelm Radue;Paul O'Connor;Chris Polman

  • Tract Probability Maps in Stereotaxic Spaces: Analyses of White Matter Anatomy and Tract-Specific Quantification

    Kegang Hua;Jiangyang Zhang;Setsu Wakana;Hangyi Jiang

  • Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

    Richard A. Rudick;William H. Stuart;Peter A. Calabresi;Christian Confavreux

  • Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial†

    Kathleen Hawker;Paul O'Connor;Mark S. Freedman;Peter A. Calabresi

  • Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

    Ludwig Kappos;David Li;Peter A Calabresi;Paul O'Connor

  • Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

    Peter A. Calabresi;Ernst Wilhelm Radue;Douglas Goodin;Douglas Jeffery

  • Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis

    Jennifer B. Fisher;Dina A. Jacobs;Clyde E. Markowitz;Steven L. Galetta

  • Saccade preparation inhibits reorienting to recently attended locations.

    Robert D. Rafal;Peter A. Calabresi;Cameron W. Brennan;Toni K. Sciolto

  • A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis.

    Martina Absinta;Martina Absinta;Martina Absinta;Dragan Maric;Marjan Gharagozloo;Thomas Garton

  • Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis

    Axel Petzold;Johannes F de Boer;Sven Schippling;Patrik Vermersch

  • Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

    Christine Beeton;Heike Wulff;Nathan E. Standifer;Philippe Azam

  • Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.

    Amit Bar-Or;Peter A. J. Calabresi;Douglas Arnold;Clyde Markowitz

  • Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

    Amit Bar-Or;Lama Fawaz;Boli Fan;Peter J. Darlington

  • Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

    Samantha S. Soldan;Rossana Berti;Nazi Salem;Paola Secchiero

  • Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity

    Michael D. Kornberg;Pavan Bhargava;Paul M. Kim;Vasanta Putluri

  • The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS

    Heike Wulff;Peter A. Calabresi;Rameeza Allie;Sung Yun

  • Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo- controlled, randomized phase II trial

    Ludwig Kappos;Giancarlo Comi;Hillel Panitch;Joel Oger

  • RETINAL NERVE FIBER LAYER IS ASSOCIATED WITH BRAIN ATROPHY IN MULTIPLE SCLEROSIS

    E. Gordon-Lipkin;B. Chodkowski;D. S. Reich;S. A. Smith

  • Imaging outcomes for neuroprotection and repair in multiple sclerosis trials.

    Frederik Barkhof;Peter A. Calabresi;David H. Miller;Stephen C. Reingold

Frequent Co-Authors

Laura J. Balcer
Laura J. Balcer New York University
Elliot M. Frohman
Elliot M. Frohman The University of Texas at Austin
Daniel S. Reich
Daniel S. Reich National Institutes of Health
Jerry L. Prince
Jerry L. Prince Johns Hopkins University
Aaron Carass
Aaron Carass Johns Hopkins University
Dzung L. Pham
Dzung L. Pham Henry M. Jackson Foundation
Peter C.M. van Zijl
Peter C.M. van Zijl Kennedy Krieger Institute
Fred D. Lublin
Fred D. Lublin Icahn School of Medicine at Mount Sinai
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare career paths is valuable if you're considering studying Medicine in the USA. Online programs now offer more flexibility and accessibility for aspiring professionals at different stages. For those with a non-nursing background, direct entry nurse practitioner programs for non-nurses online present a fast-track option to enter advanced practice roles in nursing.

If you're seeking less competitive admissions, consider institutions known as the easiest rn program choices. These programs often have higher acceptance rates and still provide solid nursing education foundations. Some schools also permit applicants to bypass common entrance exams — check out nursing programs without teas for more details.

Another promising path is in healthcare administration. Accredited medical billing and coding financial aid programs make it easier for students to start a rewarding career with manageable tuition options. Each of these pathways can open doors to respected roles in healthcare — even if your initial path isn't traditional medical school.

Best Scientists Citing Peter A. Calabresi

Trending Scientists

Recently Published Articles